Stefania Cannito

Dr. Stefania Cannito

Department of Clinical and Biological Sciences, University of Torino, 10125, Torino, Italy
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2008 in Carcinogenesis
Verified
Journal Article
Closed access
PDF file
Stefania CannitoStefania Cannito
Stefania Cannito
ENErica Novo
Erica Novo
ACAlessandra Compagnone
Alessandra Compagnone
LBLorenzo Valfrè di Bonzo
Lorenzo Valfrè di Bonzo
CBChiara Busletta
Chiara Busletta
MPMaurizio Parola
Maurizio Parola
Epithelial–mesenchymal transition (EMT) and hypoxia are considered as crucial events favouring invasion and metastasis of many cancer cells. In this study, different human neoplastic cell lines of epithelial origin were exposed to hypoxic conditions in order to investigate whether hypoxia per se may trigger EMT programme as well as to mechanistically elucidate signal transduction mechanisms involved. The following human cancer cell lines were used: HepG2 (from human hepatoblastoma), PANC-1 (from pancreatic carcinoma), HT-29 (from colon carcinoma) and MCF-7 (from breast carcinoma). Cancer cells were exposed to carefully controlled hypoxic conditions and investigated for EMT changes and signal transduction by using morphological, cell and molecular biology techniques. All cancer cells responded to hypoxia within 72 h by classic EMT changes (fibroblastoid phenotype, SNAIL and β-catenin nuclear translocation and changes in E-cadherin) and by increased migration and invasiveness. This was involving very early inhibition of glycogen synthase kinase-3β (GSK-3β), early SNAIL translocation as well as later and long-lasting activation of Wnt/β-catenin-signalling machinery. Experimental manipulation, including silencing of hypoxia-inducible factor (HIF)-1α and the specific inhibition of mitochondrial generation of reactive oxygen species (ROS), revealed that early EMT-related events induced by hypoxia (GSK-3β inhibition and SNAIL translocation) were dependent on transient intracellular increased generation of ROS whereas late migration and invasiveness were sustained by HIF-1α- and vascular endothelial growth factor (VEGF)-dependent mechanisms. These findings indicate that in cancer cells, early redox mechanisms can switch on hypoxia-dependent EMT programme whereas increased invasiveness is sustained by late and HIF-1α-dependent release of VEGF.

16 July 2007 in Gut
Verified
Journal Article
Closed access
PDF file
LBL Valfrè di Bonzo
L Valfrè di Bonzo
IFIvana Ferrero
Ivana Ferrero
CCC Cravanzola
C Cravanzola
KMKatia Mareschi
Katia Mareschi
DRD Rustichell
D Rustichell
MPMaurizio Parola
Maurizio Parola
Background and aim: Mesenchymal stem cells from bone marrow (MSCs) may have the potential to differentiate in vitro and in vivo into hepatocytes. We investigated whether transplanted human MSCs (hMSCs) may engraft the liver of non-obese diabetic severe combined immuno-deficient (NOD/SCID) mice and differentiate into cells of hepatic lineage. Methods: Ex vivo expanded, highly purified and functionally active hMSCs from bone marrow were transplanted (caudal vein) in sublethally irradiated NOD/SCID mice that were either exposed or not to acute liver injury or submitted to a protocol of chronic injury (single or chronic intraperitoneal injection of CCl4, respectively). Chimeric livers were analysed for expression of human transcripts and antigens. Results: Liver engraftment of cells of human origin was very low in normal and acutely injured NOD/SCID mice with significantly higher numbers found in chronically injured livers. However, hepatocellular differentiation was relatively rare, limited to a low number of cells (ranging from less than 0.1% to 0.23%) as confirmed by very low or not detectable levels of human transcripts for α-fetoprotein, CK18, CK19 and albumin in either normal or injured livers. Finally, a significant number of cells of human origin exhibited a myofibroblast-like morphology. Conclusions: Transplanted hMSCs have the potential to migrate into normal and injured liver parenchyma, particularly under conditions of chronic injury, but differentiation into hepatocyte-like cells is a rare event and pro-fibrogenic potential of hMSC transplant should be not under-evaluated.

1 June 2007 in The American Journal of Pathology
Verified
Journal Article
Closed access
ENErica Novo
Erica Novo
Stefania CannitoStefania Cannito
Stefania Cannito
EZElena Zamara
Elena Zamara
LBLorenzo Valfrè di Bonzo
Lorenzo Valfrè di Bonzo
ACAlessandra Caligiuri
Alessandra Caligiuri
MPMaurizio Parola
Maurizio Parola

19 January 2006 in Gut
Verified
Journal Article
Closed access
PDF file
ENE Novo
E Novo
FMFabio Marra
Fabio Marra
EZE Zamara
E Zamara
LBL Valfrè di Bonzo
L Valfrè di Bonzo
LML Monitillo
L Monitillo
MPMaurizio Parola
Maurizio Parola
Background and aims: Myofibroblast-like cells, originating from activation of hepatic stellate cells (HSC/MFs), play a key role in liver fibrosis, a potentially reversible process that may rely on induction of HSC/MFs apoptosis. While this possibility has been shown in cultured rat HSC, very limited data are currently available for human HSC/MFs. Methods: Cultured human HSC/MFs were exposed to several proapoptotic stimuli, including those known to induce apoptosis in rat HSC/MFs, and induction of cell death and related mechanisms were investigated using morphology, molecular biology, and biochemical techniques. Results: In this study we report that fully activated human HSC/MFs did not undergo spontaneous apoptosis and survived to prolonged serum deprivation, Fas activation, or exposure to nerve growth factor, tumour necrosis factor α (TNF-α), oxidative stress mediators, doxorubicin, and etoposide. Induction of caspase dependent, mitochondria driven apoptosis in HSC/MFs was observed only when protein synthesis or transcription were inhibited. Importantly, the process of HSC activation was accompanied by changes in expression of a set of genes involved in apoptosis control. In particular, activated human HSC/MFs in culture overexpressed Bcl-2. The role of Bcl-2 was crucial as Bcl-2 silenced cells became susceptible to TNF-α induced apoptosis. Finally, Bcl-2 was markedly expressed in HSC/MFs present in liver tissue obtained from patients with hepatitis C virus related cirrhosis. Conclusions: Human activated HSC/MFs are resistant to most proapoptotic stimuli due to Bcl-2 overexpression and this feature may play a key role in the progression of fibrosis in chronic liver diseases.

Verified
Journal Article
Open access
PDF file
BFBeatrice Foglia
Beatrice Foglia
Cristian TuratoCristian Turato
Cristian Turato
Stefania CannitoStefania Cannito
Stefania Cannito
The most common form of primary liver malignancy is hepatocellular carcinoma (HCC)

Verified
Journal Article
Open access
PDF file
BFBeatrice Foglia
Beatrice Foglia
Stefania CannitoStefania Cannito
Stefania Cannito
Claudia BoccaClaudia Bocca
Claudia Bocca
MPMaurizio Parola
Maurizio Parola
Erica NovoErica Novo
Erica Novo
Fibrogenic progression of chronic liver disease, whatever the etiology, is characterized by persistent chronic parenchymal injury, chronic activation of inflammatory response, and sustained activation of liver fibrogenesis, and of pathological wound healing response. A critical role in liver fibrogenesis is played by hepatic myofibroblasts (MFs), a heterogeneous population of α smooth-muscle actin—positive cells that originate from various precursor cells through a process of activation and transdifferentiation. In this review, we focus the attention on the role of extracellular signal-regulated kinase (ERK) signaling pathway as a critical one in modulating selected profibrogenic phenotypic responses operated by liver MFs. We will also analyze major therapeutic antifibrotic strategies developed in the last two decades in preclinical studies, some translated to clinical conditions, designed to interfere directly or indirectly with the Ras/Raf/MEK/ERK signaling pathway in activated hepatic MFs, but that also significantly increased our knowledge on the biology and pathobiology of these fascinating profibrogenic cells.